U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07590830) titled 'Intravenous Lidocaine for Hepatectomy' on April 22.
Brief Summary: Liver resection is increasingly performed for hepatic tumors, mainly primary liver cancers and resectable metastases, but also for some benign lesions. Postoperative pain is often significant, regardless of the surgical technique, making effective pain control essential to promote early mobilization and reduce complications.
Current standard care relies on multimodal analgesia, combining several drugs administered during surgery, with morphine administered as rescue therapy when required. Morphine is associated with side effects such as nausea, vomiting, ileus, hypox...